ZymoGenetics to Gain Access to Lexicon's OmniBank Database | GenomeWeb

THE WOODLANDS, Tex.--Lexi con Genetics here has announced a functional genomics research agreement with ZymoGe netics, the US healthcare research affiliate of the Danish company Novo Nordisk. The multiyear deal grants both ZymoGenetics and Novo Nordisk nonexclusive access to Lexicon's OmniBank gene sequence database, which corresponds to a library of novel mutant mouse embryonic stem cell clones, as well as allowing for the rapid generation of novel mouse mutants for use in ZymoGenetics' programs in gene functional analysis and drug discovery.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.